Could not agree more. It’s a shame that the good OTC companies don’t do enough PRs and the bad ones do too many.
I have gotten responses from David, but not a clear cut answer on their strategy for raising awareness. Hopefully they have something in mind, because 1, this should not be at these levels and 2, this should not be struggling to find buyers.
Market Data 
Markets 
AI
